Long-term follow-up of three-timesweekly glatiramer acetate: 7-year results of the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study

Authors
Category Primary study
JournalEuropean Journal of Neurology
Year 2020
This article has no abstract
Epistemonikos ID: 0c5688e32a79570ee79bf5040e93de6161625678
First added on: Feb 12, 2025